Bank of America’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-274
Closed -$4 8516
2024
Q1
$4 Buy
+274
New +$6 ﹤0.01% 7608
2023
Q4
Sell
-100
Closed -$4 8295
2023
Q3
$4 Buy
+100
New +$5 ﹤0.01% 7686
2023
Q2
Sell
-102
Closed -$7 8034
2023
Q1
$7 Buy
+102
New +$6 ﹤0.01% 7662

Bank of America's ARTLW Position: Q2 2024 in Review

Bank of America sold out of Artelo Biosciences, Inc. Warrant (ARTLW) in Q2 2024, closing a stake of 274 shares — an estimated $4 sold.

Bank of America first reported a position in ARTLW in Q1 2023 and held it in 3 quarters. The position peaked at $7 in Q1 2023. 0 funds tracked by Wall St. Rank hold ARTLW as of Q2 2024.

  • Bank of America reported no remaining Artelo Biosciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 274 Artelo Biosciences, Inc. Warrant shares in Q2 2024, an estimated $4.
  • Bank of America first reported a position in Artelo Biosciences, Inc. Warrant in Q1 2023 and held it in 3 quarters.
  • Bank of America's Artelo Biosciences, Inc. Warrant position peaked at $7 in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Artelo Biosciences, Inc. Warrant as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.